Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing
Bloomberg Talks
Intro
This chapter explores a pharmaceutical company's recent acquisition of a breast cancer program from a biotech firm. The discussion highlights the strategic importance of this deal in enhancing oncology offerings and improving treatment outcomes for women with breast cancer.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
